Pancreatic Cancer: Yesterday, Today and Tomorrow
Tóm tắt
Từ khóa
Tài liệu tham khảo
Morgagni G . De Sedibus, et Causis Morborum per Anatomen Indagatis Libri Quinque. Venetiis, Typog Remondiniana (1761).
Da Costa J . On the Morbid Anatomy and Symptoms of Cancer of the Pancreas. JB Lippincott & Company, Philadelphia, PA, USA (1858).
Codivilla A . Rendiconto statistico della sezione chirurgica dell’ospedale di Imola. Imola Italy (1898).
Kausch W . Das carcinom der papilla duodeni und seine radikale entfernung. Beitr. Klin. Chir.78, 439–486 (1912).
Hirschel G . Die resektion des duodenums mit der papille wegen karzinoms. Munch. Med. Wochenschr.61, 1728–1729 (1914).
Whipple AO . Observations on radical surgery for lesions of the pancreas. Surg. Gynecol. Obstet.82, 623–631 (1946).
Whipple AO . A reminiscence: pancreaticduodenectomy. Rev. Surg.20, 221–225 (1963).
Brunschwig A . Resection of the head of pancreas and duodenum for carcinoma – pancreatoduodenectomy. Surg. Gynecol. Obstet.65, 681–684 (1937).
AJCC Cancer Staging Manual (7th Edition) . Springer, NY, USA (2010).
National Comprehensive Cancer Network . Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma. Version 2 (2015). www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Moore GE , SakoY, ThomasLB. Radical pancreatoduodenectomy with resection and reanastomosis of the superior mesenteric vein. Surgery30(3), 550–553 (1951).
Fortner JG . Regional resection of cancer of the pancreas: a new surgical approach. Surgery73(2), 307–320 (1973).
Hammel P , HuguetF, Van LaethemJet al. Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: final results of the international Phase III LAP 07 study. J. Clin. Oncol.31(Suppl. 18), Abstract LBA4003 (2013).
Haywood A , GoodP, KhanSet al. Corticosteroids for the management of cancer-related pain in adults. Cochrane Database Syst. Rev.4, CD010756 (2015).
Hingorani S , HarrisW, HendifarAet al. High response rate and PFS with PEGPH20 added to nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized Phase II study. J. Clin. Oncol.33(Suppl.), Abstract 4006 (2015).
Hingorani S , HarrisW, BeckJet al. Final results of a phase Ib study of gemcitabine plus PEGPH20 in patients with stage IV previously untreated pancreatic cancer. J. Clin. Oncol.33(Suppl. 3), Abstract 359 (2015).
Warburg O . On the metabolism of carcinoma cells. Biochem. Z.152, 309–344 (1924).
